Lexicon Pharmaceuticals, Inc. financial data

Symbol
LXRX on Nasdaq
Industry
Pharmaceutical Preparations
Location
2445 Technology Forest Blvd., Suite 1100, The Woodlands, TX
State of incorporation
Delaware
Fiscal year end
December 31
Former names
LEXICON PHARMACEUTICALS, INC./DE (to 12/5/2014), LEXICON GENETICS INC/TX (to 4/2/2007)
Latest financial report
10-Q - Q2 2024 - Aug 2, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 943 % +27.2%
Quick Ratio 1.58 %
Debt-to-equity 70.3 % +14.1%
Return On Equity -106 % -8.74%
Return On Assets -62.4 % -3.21%
Operating Margin -5.41K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 361M shares +47.6%
Entity Public Float 274M USD +104%
Common Stock, Value, Issued 363K USD +48.2%
Weighted Average Number of Shares Outstanding, Basic 311M shares +51.8%
Weighted Average Number of Shares Outstanding, Diluted 311M shares +51.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 3.64M USD +420%
Revenue from Contract with Customer, Excluding Assessed Tax 3.53M USD +456%
Research and Development Expense 64.3M USD +25.9%
Costs and Expenses 201M USD +27.9%
Operating Income (Loss) -197M USD -53%
Net Income (Loss) Attributable to Parent -202M USD -54.6%
Earnings Per Share, Basic -0.78 USD/shares -13%
Earnings Per Share, Diluted -0.78 USD/shares +22.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 35.6M USD -65.2%
Accounts Receivable, after Allowance for Credit Loss, Current 2.62M USD +282%
Inventory, Net 585K USD +240%
Other Assets, Current 7.68M USD +25.3%
Assets, Current 321M USD +21.7%
Property, Plant and Equipment, Net 1.95M USD -11.3%
Operating Lease, Right-of-Use Asset 5.19M USD -17.7%
Goodwill 44.5M USD 0%
Other Assets, Noncurrent 828K USD -86.8%
Assets 373M USD +17.9%
Accounts Payable, Current 12.2M USD +16.4%
Employee-related Liabilities, Current 9.17M USD
Accrued Liabilities, Current 15.7M USD +0.31%
Liabilities, Current 27.9M USD +6.77%
Long-term Debt and Lease Obligation 5.48M USD +447%
Operating Lease, Liability, Noncurrent 4.89M USD
Other Liabilities, Noncurrent 6M USD +9.47%
Liabilities 133M USD +2.31%
Accumulated Other Comprehensive Income (Loss), Net of Tax -193K USD -93%
Retained Earnings (Accumulated Deficit) -1.87B USD -12.1%
Stockholders' Equity Attributable to Parent 240M USD +28.8%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 240M USD +28.8%
Liabilities and Equity 373M USD +17.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -55.1M USD -74.4%
Net Cash Provided by (Used in) Financing Activities 239M USD
Net Cash Provided by (Used in) Investing Activities -110M USD -1011%
Common Stock, Shares Authorized 450M shares
Common Stock, Shares, Issued 363M shares +47.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 74M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 35.6M USD -65.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3.26M USD +109%
Deferred Tax Assets, Valuation Allowance 390M USD +12.8%
Cash and Cash Equivalents, Period Increase (Decrease) -4.55M USD +84.1%
Deferred Tax Assets, Gross 392M USD +12.9%
Operating Lease, Liability 6.18M USD -8.8%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -202M USD -54.7%
Lessee, Operating Lease, Liability, to be Paid 9.3M USD -11.7%
Property, Plant and Equipment, Gross 3.79M USD
Operating Lease, Liability, Current 1.29M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.22M USD -11.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 691K USD +28%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 Rate
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.12M USD -16.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 865K USD -29.1%
Deferred Tax Assets, Operating Loss Carryforwards 288M USD +14.7%
Preferred Stock, Shares Issued 2.3M shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 881K USD +1.85%
Additional Paid in Capital 2.11B USD +13.9%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 144K USD +28.6%
Share-based Payment Arrangement, Expense 4.9M USD +28.9%
Operating Leases, Future Minimum Payments, Due in Three Years 1.22M USD +124%
Operating Leases, Future Minimum Payments Due 10.8M USD +314%
Interest Expense 8.78M USD +345%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%